Find out how NAMs are influencing safety assessments and decision-making in the pharmaceutical industry ahead of 2026.
Explore the role of the cPLA2 enzyme in brain inflammation related to Alzheimer’s disease and its potential as a therapeutic target.
Explore new findings on drug-resistant breast cancer and how targeting cell cycle regulators may improve treatment outcomes.
Starting soon, the 16th World ADC London (23rd–26th February), the longest-standing and pre-eminent ADC-focused forum in Europe, serves as the definitive one-stop shop for the European ADC community ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results